Tag: NMITLI

News:The Council of Scientific and Industrial Research(CSIR) has sanctioned a project to develop human monoclonal antibodies as a therapy for Covid-19 in the next six months. Facts: The project was approved under CSIR’s New Millennium Indian Technology Leadership Initiative(NMITLI). Aim: To create an alternate therapy by generating highly effective and specific human monoclonal antibodies capable… Continue reading Bharat Biotech eyes human monoclonal antibody therapy for Covid-19